were isolated from the nBuOH fraction of the roots of Cimicifuga foetida. Their structures were elucidated on the basis of spectroscopic and chemical reaction data.
Introduction
The Traditional Chinese Medicine Rhizoma Cimicifugea is used to treat toothache, mouth ulcers, sore throats and to help erupt measles [1] . The Chinese Pharmacopoeia describes three Cimicifuga species (C. foetida, C. dahurica and C. heracleifolia) as the crude drug source [1] , among which C. foetida is found widely spread throughout northwest Yunnan Province [2] .
Ever since three trinor-cycloartanes were found in C. foetida by Asian research groups between 1994-96 [3] [4] [5] [6] [7] , no additional compounds with such structure have been reported, as far as we know. While we were carrying out a phytochemical investigation on antitumor triterpenes of Cimiciguga OPEN ACCESS species in Yunnan Province [8] [9] [10] [11] , three new trinor-cycloartane glycosides 1-3 were isolated from the roots of C. foetida ( Figure 1 ). The UV data [(MeOH) λ max (logε) nm: 282(3.4), 321(3.4)] suggested the presence of an α,β-unsaturated ketone group. The 13 C-NMR (Table 1 ) and DEPT spectra of 1 displayed 32 signals, of which 27 were attributed to a trinor-triterpene skeleton and five to a β-D-xylopyranose moiety [δ C 67.2 t (C-5'), 71. [3] , except that an olefinic bond between C-16 and C-24 in 1 formed an enone group with the carbonyl group at C-23. The assignments were confirmed by the HMBC correlations of H-15 with C-14, C-16, C-24 and C-28, of H-22 with C-17, C-20, C-21, C-23 and C-24, and of H-17 with C-13, C-16, C-18 and C-20 ( Figure 2 ). An α-orientation for OH-15 was deduced from the ROESY correlations of H-15 with 3H-18. Therefore, the structure was established as 15α-hydroxy-16-dehydroxy-16(24)-en-foetidinol-3-O-β-D-xylopyranoside. (Table 1) with those of 15α-hydroxy-foetidinol-3-O-β-D-xyloside, a methyl in the known compound was hydroxylated into a methylene at δ C 67.4 in 2, which was located at C-28 by the HMBC associations of H-28 with C-8, C-12 and C-14, H-12 with C-13, C-14, C-17 and C-28. In addition, the other four methyls had no possibility to be hydroxylated due to 3H-21 and 3H-18 showed HMBC correlations with C-17 while 3H-29 and 3H-30 correlated with C-3, C-4 and C-5. Thus, the structure of 2 was elucidated as 28-hydroxy-foetidinol-3-O-β-D-xylopyranoside. (Table 1) of the aglycon moiety were in good agreement with those of foetidinol aglycone [3] , however, the ten additional resonances in the 
Experimental

General
Optical rotations: Horiba SEPA-300 polarimeter. UV spectra: Shimadzu UV-2401A spectrophotometer. IR spectra: Bio-Rad FTS-135 infrared spectrophotometer. C-NMR and 2D-NMR spectra: Bruker AM-400 MHz or DRX-500 spectrometers with TMS as internal standard. MS: VG Autospec-300, Finnigan MAT-90 and API Qstar-Plusar-1 spectrometers. The pentose authentic samples were purchased from Acros Organics.
Plant material
The roots of C. foetida were collected in Daju Village of Lijiang County, Yunnan Province in July 2004 and identified by Prof. Pei Shengji (Kunming Institute of Botany, the Chinese Academy of Sciences). The voucher specimen (KIB 04072601) has been deposited at the State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences.
Extraction and Isolation
Air-dried and powdered roots of C. foetida (10 kg C-NMR data, see Table 1 . 
Conclusions
Since three trinor-cycloartanes were found for the first time in C. foetida between 1994 and 1996, no such type of structure have been reported in past ten years. The new compounds found were trace constituents compared with foetidinol-3-O-β-D-xylopyranoside, and presumably are formed as side products or intermediates due to elimination, oxygenation or glycosylation reactions during the biosynthesis of this compound [12] . They suggest a diversity of trinor-cycloartane structures and the high-content of foetidinol-related structures found in Daju village of Lijiang County made the C. foetida growing in this area a new resource of novel trinor-cycloartane structures.
